Annual Cash & Cash Equivalents
$69.59 M
+$66.42 M+2090.53%
December 31, 2021
Summary
- As of February 10, 2025, EYES annual cash & cash equivalents is $69.59 million, with the most recent change of +$66.42 million (+2090.53%) on December 31, 2021.
- During the last 3 years, EYES annual cash & cash equivalents has risen by +$65.12 million (+1456.54%).
Performance
EYES Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$56.38 M
-$3.22 M-5.41%
June 30, 2022
Summary
- As of February 10, 2025, EYES quarterly cash and cash equivalents is $56.38 million, with the most recent change of -$3.22 million (-5.41%) on June 30, 2022.
- Over the past year, EYES quarterly cash and cash equivalents has dropped by -$17.47 million (-23.65%).
Performance
EYES Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
EYES Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2090.5% | -23.6% |
| 3 y3 years | +1456.5% | +124.1% |
| 5 y5 years | +787.8% | +7288.9% |
EYES Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -19.0% | at low |
| 5 y | 5-year | at high | -95.4% | -23.7% | -95.9% |
| alltime | all time | at high | -99.9% | -23.7% | -99.9% |
Second Sight Medical Products Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $56.38 M(-5.4%) |
| Mar 2022 | - | $59.60 M(-14.4%) |
| Dec 2021 | $69.59 M(+2090.5%) | $69.59 M(-3.4%) |
| Sep 2021 | - | $72.03 M(-2.5%) |
| Jun 2021 | - | $73.84 M(+174.9%) |
| Mar 2021 | - | $26.86 M(+745.5%) |
| Dec 2020 | $3.18 M(-72.0%) | $3.18 M(+30.4%) |
| Sep 2020 | - | $2.44 M(-30.5%) |
| Jun 2020 | - | $3.50 M(+49.9%) |
| Mar 2020 | - | $2.34 M(-79.4%) |
| Dec 2019 | $11.33 M(+153.3%) | $11.33 M(-38.6%) |
| Sep 2019 | - | $18.46 M(-26.6%) |
| Jun 2019 | - | $25.16 M(-20.6%) |
| Mar 2019 | - | $31.68 M(+608.6%) |
| Dec 2018 | $4.47 M(-43.0%) | $4.47 M(-10.1%) |
| Sep 2018 | - | $4.97 M(-33.5%) |
| Jun 2018 | - | $7.48 M(+49.1%) |
| Mar 2018 | - | $5.01 M(-36.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | $7.84 M(+1354.4%) | $7.84 M(+1126.8%) |
| Sep 2017 | - | $639.00 K(-16.3%) |
| Jun 2017 | - | $763.00 K(+186.8%) |
| Mar 2017 | - | $266.00 K(-50.6%) |
| Dec 2016 | $539.00 K(+125.5%) | $539.00 K(+94.6%) |
| Sep 2016 | - | $277.00 K(+50.5%) |
| Jun 2016 | - | $184.00 K(-59.9%) |
| Mar 2016 | - | $459.00 K(+92.1%) |
| Dec 2015 | $239.00 K(-61.4%) | $239.00 K(-11.1%) |
| Sep 2015 | - | $268.70 K(-34.0%) |
| Jun 2015 | - | $407.40 K(-37.5%) |
| Mar 2015 | - | $652.30 K(+5.4%) |
| Dec 2014 | $619.00 K(+888.8%) | $619.00 K(-36.7%) |
| Sep 2014 | - | $977.40 K(-66.8%) |
| Jun 2014 | - | $2.95 M(+551.1%) |
| Mar 2014 | - | $452.60 K(+623.0%) |
| Dec 2013 | $62.60 K(-56.8%) | $62.60 K |
| Dec 2012 | $144.80 K | - |
FAQ
- What is Second Sight Medical Products annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Second Sight Medical Products?
- What is Second Sight Medical Products annual cash & cash equivalents year-on-year change?
- What is Second Sight Medical Products quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Second Sight Medical Products?
- What is Second Sight Medical Products quarterly cash and cash equivalents year-on-year change?
What is Second Sight Medical Products annual cash & cash equivalents?
The current annual cash & cash equivalents of EYES is $69.59 M
What is the all time high annual cash & cash equivalents for Second Sight Medical Products?
Second Sight Medical Products all-time high annual cash & cash equivalents is $69.59 M
What is Second Sight Medical Products annual cash & cash equivalents year-on-year change?
Over the past year, EYES annual cash & cash equivalents has changed by +$66.42 M (+2090.53%)
What is Second Sight Medical Products quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of EYES is $56.38 M
What is the all time high quarterly cash and cash equivalents for Second Sight Medical Products?
Second Sight Medical Products all-time high quarterly cash and cash equivalents is $73.84 M
What is Second Sight Medical Products quarterly cash and cash equivalents year-on-year change?
Over the past year, EYES quarterly cash and cash equivalents has changed by -$17.47 M (-23.65%)